Published in Healthcare Mergers, Acquisitions and Ventures Week, October 15th, 2005
The convertible notes are convertible into 9,672,925 million shares of common stock at a price of $2.30 per share.
The investors also received warrants to purchase 4,836,462 million additional shares of common stock at a price of $2.53 per share exercisable for 5 years. T.R. Winston & Company acted as placement agent for the securities sold in this transaction.
The proceeds of the financing are expected to be used by the company for general corporate purposes and to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.